The published patients with pathogenic PLIN1 variants had dyslipidemia with hypertriglyceridemia (range from 2 to 147 mmol/L) (1, 5); all of the patients in our study with variants in PLIN1 had triglyceride levels below 1.7 mmol/L. The gene discussed is PLIN1; the disease is metabolic syndrome.